“Current status of anti-CD30 monoclonal antibody therapy in anaplastic lymphoma and Hodgkin’s lymphoma” (2009) Hematology Meeting Reports (formerly Haematologica Reports), 2(13). doi:10.4081/hmr.v2i13.483.